Sort
326,823 grants matching “clinical trial”
Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases
$2,567,925Edward A Fisher · New York University School Of Medicine · P01 · FY2022 · HL
Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases
$2,567,925Edward A Fisher · New York University School Of Medicine · P01 · FY2023 · HL
Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases
$2,567,925Edward A Fisher · New York University School Of Medicine · P01 · FY2025 · HL
"REAL Answers" (Registry Expansion Analyses to Learn)
$2,567,678Jeffrey Avins Glassberg · Icahn School Of Medicine At Mount Sinai · U01 · FY2023 · HL
Targeted Therapies in Melanoma
$2,567,345Meenhard Herlyn · Wistar Institute · P01 · FY2013 · CA
EARLY TMT/RETINOPATHY OF PREMATURITY (ETROP)- COORD CTR
$2,566,925University Of Texas Hlth Sci Ctr Houston · U10 · FY2000 · EY
Northwestern University Clinical Trial Unit
$2,566,649Robert L. Murphy · Northwestern University At Chicago · U01 · FY2008 · AI
Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease
$2,566,363Jessica Alber · University Of Rhode Island · R01 · FY2022 · AG
Community Clinical Oncology Program
$2,566,072Mayo Clinic · U10 · FY2004 · CA
Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)
$2,565,829Douglas Allen Corley · Kaiser Foundation Research Institute · UM1 · FY2021 · CA
CARCINOGENIC SIGNIFICANCE OF HETERCYCLIC AMINES
$2,565,593University Of Calif-Lawrnc Lvrmr Nat Lab · P01 · FY2004 · CA
THE UW/FHCRC PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,565,002University Of Washington · U01 · FY2000 · HL
Defining Melanoma Therapeutic Avenues by Integrative Functional Genomics
$2,565,000Levi Alexander Garraway · Dana-Farber Cancer Inst · DP2 · FY2007 · OD
Clinical Studies of Vaccines for Pandemic Influenza
$2,564,575Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Molecular Targeting of Developmental Cancers in Children
$2,564,487Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
$2,564,339James R. Heath · Institute For Systems Biology · U54 · FY2025 · CA
Sexually Transmitted Infections Clinical Trials Group
$2,564,303Giudice Linda · University Of California, San Francisco · N01 · FY2017 · AI
Dental PBRN Network Chair
$2,564,035Gregg H Gilbert · University Of Alabama At Birmingham · U01 · FY2009 · DE
Mechanisms and Therapy of Chronic Graft-vs.-Host Disease
$2,563,941Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2025 · HL
Genetics and Bioinformatics Core Laboratory
$2,563,727Daniel Weinberger · National Institute Of Mental Health · ZIC · FY2009 · MH
Improving Uptake of Cervical Cancer Prevention Services in Appalachia
$2,563,376Electra D. Paskett · Ohio State University · P01 · FY2019 · CA
The role of stem cells in skeletal health and disease
$2,563,233Pamela G Robey · National Institute Of Dental & Craniofacial Research · ZIA · FY2018 · DE
Models For Tobacco Product Evaluation
$2,563,112Dorothy K Hatsukami · University Of Minnesota · U19 · FY2014 · CA
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)
$2,562,872Linmarie Sikich · Univ Of North Carolina Chapel Hill · U01 · FY2014 · HD
Development Of New Approaches To Vaccines Against TBEV and West Nile Virus
$2,562,752Alexander Pletnev · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI